| Literature DB >> 33688672 |
Raffaele Vardavas1, Pedro Nascimento de Lima1, Lawrence Baker1.
Abstract
We developed a COVID-19 transmission model used as part of RAND's web-based COVID-19 decision support tool that compares the effects of nonpharmaceutical public health interventions (NPIs) on health and economic outcomes. An interdisciplinary approach informed the selection and use of multiple NPIs, combining quantitative modeling of the health/economic impacts of interventions with qualitative assessments of other important considerations (e.g., cost, ease of implementation, equity). This paper provides further details of our model, describes extensions, presents sensitivity analyses, and analyzes strategies that periodically switch between a base NPI level and a higher NPI level. We find that a periodic strategy, if implemented with perfect compliance, could have produced similar health outcomes as static strategies but might have produced better outcomes when considering other measures of social welfare. Our findings suggest that there are opportunities to shape the tradeoffs between economic and health outcomes by carefully evaluating a more comprehensive range of reopening policies.Entities:
Year: 2021 PMID: 33688672 PMCID: PMC7941649 DOI: 10.1101/2021.02.28.21252642
Source DB: PubMed Journal: medRxiv
Figure 1:COVID-19 PBM disease states
Nonpharmaceutical intervention levels.
| NPI Level | Description |
|---|---|
| Level 1: No Intervention | No Intervention |
| Level 2: Close schools | All schools are closed. |
| Level 3: Close schools, bars, and restaurants; and ban large events | In addition to school closures, all bars’ and restaurants’ dine-in services are closed, only allowing for take-out options. Also, large gatherings are banned. |
| Level 4: Close schools, bars, and restaurants; ban large events; and close nonessential businesses | In addition to school, bar, and restaurant closures, all nonessential businesses are closed. |
| Level 5: Close schools, bars, and restaurants; ban large events; close nonessential businesses; and shelter in place for the most vulnerable | In addition to the closure of all nonessential businesses, a shelter in place recommended for the vulnerable population, including the elderly, children, and other at-risk populations. |
| Level 6: Close schools, bars, and restaurants; ban large events; close nonessential businesses; and shelter in place for everyone but essential workers | In addition to the interventions above, shelter in place order is issued for the everyone but essential workers. |
Figure 2:Model Dynamics with Fixed and Periodic NPIs.
Fixed NPI strategies are coded with an “F” followed by the intervention level included in the NPI. Periodic NPI strategies are coded with a “P” followed by the maximum NPI level in the periodic strategy and the period in days. In that case, P-3–14 means that the state will switch between the NPI level 3 and 1 every 14 days.
Figure 3:Tradeoff surface implied by alternative policies.
The vertical axis presents the number of Deaths / 100k at the end of the simulation run (Feb. 2021) in California, and the horizontal axis contains several proxies that represent alternative criteria to evaluate the costs of NPIs. Across all these criteria, we find that periodic NPIs tend to dominate fixed NPIs. The plot demonstrates that strategies with fixed NPIs generally are dominated by periodic NPI strategies.
Disease states included in the model. The dependence on time t is implicitly assumed.
| Disease State | Description | Infectious | Diagnosed |
|---|---|---|---|
|
| Noninfected and susceptible. | No | No |
|
| Exposed and infected but not yet infectious. | No | No |
|
| Presymptomatic infectious. | Yes | No |
|
| Nondiagnosed Infected with mild symptoms. | Yes | No |
|
| Nondiagnosed infected with severe symptoms. | Yes | No |
|
| Diagnosed infected with mild symptoms. | Yes | Yes |
|
| Diagnosed infected with severe symptoms. | Yes | Yes |
|
| Hospitalized not in the intensive-care unit. | Yes | Yes |
|
| Hospitalized in the intensive-care unit. | Yes | Yes |
|
| Nondiagnosed infected asymptomatic. | Yes | No |
|
| Diagnosed infected asymptomatic. | Yes | Yes |
|
| Recovered who were symptomatic. | No | Yes & No |
|
| Recovered who were asymptomatic. | No | Yes & No |
|
| Those who have died. | No | Yes & No |
Model strata and corresponding populations
| Non-aggregated Strata | US Unique Population (millions) | Aggregated Strata |
|---|---|---|
| Young | 73.4 | Young |
| FLEW without high-risk conditions | 36.0 | FLEW |
| Employed, but not FLEW, without high-risk conditions | 60.0 | Working age |
| Not employed without high-risk conditions | 33.2 | Working age |
| Old without high-risk conditions | 11.8 | Old |
| FLEW with high-risk conditions | 14.1 | FLEW |
| Employed, but not FLEW, with high-risk conditions | 37.6 | Working age with high-risk conditions |
| Not employed with high-risk conditions | 20.8 | Working age with high-risk conditions |
| Old with high-risk conditions | 37.6 | Old |
Disease duration parameter estimates
| Parameter | Mode | Sample Range | Sample Dist | Formula | Sources |
|---|---|---|---|---|---|
| Duration in days of incubation phase | 5 | 4 – 6 | PERT |
| [ |
| Proportion of incubation phase which is non-infectious | 60% | 50 – 70% | PERT |
| [ |
| Infectious duration in days of asymptomatic and mild disease | 5 | 4 – 7 | PERT |
| [ |
| Expected days spent in hospital (including ICU) at hospitalization | 8 | 6 – 10 | PERT |
| [ |
| Expected days spent in the ICU at ICU admission as a proportion of expected days spent in the hospital at hospitalization | 90% | 80 – 100% | PERT |
| [ |
| Months before loss of natural immunity | 20 | 10 – 40% | PERT |
| [ |
Disease prognosis parameter estimates
| Parameter | Mode | Sample Range | Sample Dist | Formula | Sources |
|---|---|---|---|---|---|
| Proportion of infections which are asymptomatic | 25% | 15 – 50% | PERT |
| [ |
| Proportion of symptomatic infections which are severe (require hospitalization) | 5% | 3 – 7% | Uniform |
| See |
| Proportion of severe cases which are critical (require ICU admission) | 32% | 26 – 38% | PERT |
| [ |
| Initial proportion of critical cases which result in death | 75% | 70 – 80% | PERT |
| [ |
| Reduction in ICU death proportion as treatment improves | 50% | 40 – 60% | PERT | N/A | [ |
| Time period over which treatment improves (months) | 6 | 4.8 – 7.2 | PERT | N/A | [ |
Relative infectivity parameter estimates
| Infectivity of phase relative to asymptomatic phase | Mode | Sample Range | Sample Dist | Sources |
|---|---|---|---|---|
| Pre-symptomatic infectious | 2.07 | 1.65 – 2.48 | PERT | [ |
| Mild symptomatic | 0.83 | 0.66 – 1.00 | PERT | [ |
| Severe symptomatic | 0.14 | 0.11 – 0.17 | PERT | [ |
| Hospitalized | 0.07 | 0.06 – 0.08 | PERT | [ |
| Tested mild symptomatic | 0.28 | 0.22 – 0.33 | PERT | [ |
| Tested severe symptomatic | 0.14 | 0.11 – 0.17 | PERT | [ |
| Tested asymptomatic | 0.20 | 0.16 – 0.24 | PERT | [ |
Other parameter estimates
| Parameter | Mode | Sample Range | Sample Dist | Formula | Sources |
|---|---|---|---|---|---|
| Per person daily detection rate for those not yet exposed | 0.002 | 0.001 – 0.004 | PERT |
| See |
| Per person daily detection rate for those who are asymptomatic | 0.01 | 0.005 – 0.04 | PERT |
| See |
| Per person daily detection rate for those who are symptomatic | 0.2 | 0.1 – 0.8 | PERT |
| See |
| Impact of seasonality | 0.2 | 0.15 – 0.3 | PERT |
| See |
| Increased progression rate for tested individuals | 2 | 1.33 – 4 | PERT |
| See |
| Effectiveness of NPIs | 2 | 0.5 – 3.5 | PERT |
| See |
Shortened parameter labels of the most significant parameters found by the sensitivity analyses.
| Parameter | Denoted |
|---|---|
| Proportion of incubation phase which is non-infectious | Proportion Non- infectious Incubation |
| Proportion of symptomatic infections which are severe (require hospitalization) | Proportion Severe |
| Proportion of severe cases which are critical (require ICU admission) | Proportion Critical |
| Proportion of infections which are asymptomatic | Proportion Asymptomatic |
| Initial proportion of critical cases which result in death | Proportion die in the ICU |
| Duration of incubation phase | Incubation Days |
| Expected time spent in hospital (including ICU) at hospitalization | Hospitalized Days |
| Infectious duration of asymptomatic and mild disease | Symptomatic Mild Days |
| Per person daily detection rate for those who are asymptomatic | zetaA |
| Per person daily detection rate for those who are symptomatic | zetaS |
| Infectivity of phase of the mild symptomatic relative to asymptomatic phase | m.Sm |
| Infectivity of phase of the severe symptomatic relative to asymptomatic phase | m.Ss |